How RBC Capital Called A 50% Gain In This Biotech Stock

Loading...
Loading...
x
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorBiotechNewsHealth CareHotAnalyst RatingsMoversGeneralBurt AdelmanDX-2930RBCRBC Capital
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...